Literature Review · Peer-Reviewed Sources Only

Hamilton Incyte Arc: Performance Review from 9 Peer-Reviewed Studies

Published May 20, 2026 · 14 min read · 9 citations
Hamilton Incyte Arc - capacitance viable cell density sensor schematic diagram stirred-tank bioreactor + - + - + - + - Arc microtransmitter Modbus 4-20 mA Radio-frequency dielectric measurement 300 kHz to 10 MHz field polarises intact cell membranes; permittivity (pF/cm) scales with viable cell volume. Viable cells only Dead cells, debris, microcarriers and gas bubbles do not hold charge and are largely excluded from the signal. Hamilton Incyte Arc - in-line viable cell density sensor
Figure 1: The Hamilton Incyte Arc inserts through a PG13.5 vessel port and applies a radio-frequency electric field (300 kHz to 10 MHz) at its electrode tip. Cells with intact membranes polarise and behave as tiny capacitors, so the measured permittivity (in pF/cm) is proportional to viable cell volume. Dead cells, cell debris, microcarriers, and gas bubbles do not store charge and are largely excluded. The Arc version integrates the microtransmitter into the probe head, delivering a digital (Modbus) and 4-20 mA signal without a separate transmitter cabinet.
Literature Verdict

Across nine peer-reviewed studies, radio-frequency dielectric capacitance is established as the standard online method for estimating viable biomass in cGMP cell culture, and the Hamilton Incyte Arc is one of the two probes that dominate that space. A BMS deployment study used Hamilton Incyte probes across bench, pilot, and GMP scales and reported capacitance linear with offline viable cell density up to 130 million cells/mL, with automated perfusion control cutting media use by about 25% [1]. The platform's documented strength is real-time, viability-weighted biomass for perfusion and feed control; its documented limitation is that the raw single-frequency signal tracks viable cell volume, not number, so it diverges from offline counts late in culture unless frequency scanning and multivariate modelling are applied [3]. No independent peer-reviewed head-to-head benchmark of the Incyte against the rival Aber FUTURA exists in the literature reviewed here.

Hamilton Incyte Arc at a glance

The Incyte Arc, from Hamilton Company, is an in-line viable cell density sensor that uses radio-frequency dielectric spectroscopy, the measurement also called capacitance or bio-capacitance. An electric field polarises cells whose membranes are intact, so each viable cell behaves as a small capacitor and the bulk permittivity scales with viable cell volume. The Arc designation means the microtransmitter is built into the probe head, removing the need for a separate transmitter. Hamilton also offers Incyte SU sensor elements pre-installed in rigid single-use vessels. Product details below are sourced from the vendor datasheet; field performance data comes from independent studies cited throughout this review.

SpecificationValue
Measurement principleRadio-frequency dielectric spectroscopy (capacitance). An applied field polarises intact cell membranes; the resulting permittivity, reported in pF/cm, is proportional to viable cell volume.
Measurement rangeTypical mammalian working range roughly 1×105 to 1×109 cells/mL, depending on cell line and calibration
Frequency range300 kHz to 10 MHz; supports a dual-frequency measurement mode and full frequency scanning
Conductivity tolerance2 to 50 mS/cm; changes within this range do not affect the capacitance reading
Accuracy (vendor-claimed)Permittivity precision approximately ±1 pF across the operating temperature range; roughly 2 to 3% capacitance accuracy
Response timeEffectively real time; live permittivity updates within seconds. The Arc module logs dual-frequency and scan data at a user-set interval (about 12 minutes typical), storing roughly 3 weeks on-probe
Operating temperature0 to 60 °C (Arc module electronics)
SterilisationReusable Incyte Arc probe body: autoclave, SIP, and CIP compatible (the detachable Arc microtransmitter module is removed before sterilisation). Incyte SU sensor elements: gamma-irradiated, pre-installed in single-use vessels of roughly 3.2 L and larger
Process connectionPG13.5 threaded port with a choice of insertion lengths; 12 mm shaft. Single-use format is an integral wall-mounted sensor patch
Output signalIntegrated Arc microtransmitter: digital (Modbus RTU) plus 4-20 mA analogue; configured over Bluetooth with Hamilton ArcAir software
Typical capital costNot published by Hamilton; quotes are dealer-mediated. Capacitance biomass channels broadly fall in the four to five figure GBP range per channel including transmitter

Spec values are taken from the Hamilton Incyte Arc product page and the Incyte SU page. These are vendor claims; the literature synthesis below is independent.

What the peer-reviewed literature says

The starting point for any honest review of the Incyte is a 2022 review of bio-capacitance in cell culture manufacturing, which concluded that capacitance has become "the standard online method to estimate biomass" in cell-based bio-manufacturing, and explained why the long-recognised divergence between capacitance and trypan blue counts in late culture is now well understood rather than a defect [6]. That review frames the trade space the Incyte sits in: the Incyte and the Aber FUTURA are the two probes that dominate mammalian cGMP biomass monitoring, and most of the development and validation literature for capacitance probes has been generated on CHO cultures. This review therefore draws on two kinds of evidence: studies that deployed Hamilton's capacitance platform specifically, and studies that characterise the dielectric-spectroscopy measurement class the Incyte belongs to. Where a finding is specific to the Incyte hardware it is flagged as such.

The clearest Incyte-specific deployment is a Bristol Myers Squibb study that built an N-1 perfusion platform around an in-line capacitance probe, using Hamilton Incyte probes at 5 L bench scale and the same probe family at 200 L pilot and 500 L GMP scale [1]. The authors reported that capacitance correlated linearly with offline viable cell density at all densities tested, up to 130 million cells/mL, an unusually high-density regime for perfusion seed cultures. Online control of the perfusion rate from the real-time capacitance signal, holding a constant cell-specific perfusion rate, cut media use by roughly 25% versus a platform volume-specific approach with no detrimental effect on cell growth. The platform was applied to six monoclonal antibody cell lines, and the small-scale capacitance data fed directly into scaling up the process into the pilot plant and GMP suite. This is the single strongest piece of evidence that the Incyte performs as a scale-independent, control-grade biomass sensor.

The accuracy story is more nuanced and is where the literature is most useful. The capacitance signal is a measure of viable cell volume, not viable cell number, so its accuracy as a viable cell density readout depends on how permittivity is converted. A Sartorius study quantified this directly: single-frequency permittivity carried 16 to 23% relative error against the offline reference, while applying multivariate analysis to a full frequency scan cut the error to 5.5 to 11%, inside the roughly 10% acceptance band of the offline method itself [3]. A Merck KGaA study reached a complementary conclusion from the modelling side: the Cole-Cole and Maxwell-Wagner conversion equations are sensitive to cell-specific parameters such as membrane capacitance and internal conductivity, and adjusting those parameters in-process with periodic offline samples improved the viable cell concentration estimate by 69% over a purely mechanistic model [4]. An earlier study introduced an "area ratio" metric that quantifies the shape of the beta dispersion from frequency-scanning data, and used it to predict viable cell volume accurately through an entire fed-batch run regardless of cell state [5]. Together these three studies make the same practical point: a capacitance probe is only as accurate as its conversion model, and frequency scanning plus multivariate or shape-aware modelling is what unlocks reliable accuracy late in culture.

Three further studies map the deployment envelope. A Biogen case study characterised the lower limit of quantitation, probe-to-probe consistency, and scalability of in situ biocapacitance probes in a commercial GMP CHO process, used the signal to automate seed-train dilution across six consecutive GMP seed trains, and later to predict future glucose demand, while also noting that capacitance can flag a shift in the salt balance of a culture [2]. A WuXi Biologics study built a real-time viable cell density auto-control loop for perfusion using a segmented adaptive PLS model on the dielectric signal, explicitly to overcome the known accuracy loss during stationary and decline phases, and held the target density with good precision and robustness across clones [7]. A Merck study extended the same dielectric-spectroscopy approach beyond antibodies, predicting both viable cell density and cell viability in real time during live-virus vaccine production using multivariate analysis across 25 frequencies, and reported that multivariate models performed markedly better than single-frequency models specifically during cell death [8]. Finally, a University of Manitoba study showed that bulk capacitance tracks intermediate-stage apoptotic cell counts rather than early-apoptotic counts, which is the mechanistic reason the signal can read higher than a trypan blue count late in a batch [9].

Performance data from cited studies

Study Conditions Accuracy Response / drift Conclusion
Rittershaus 2022 [1] Hamilton Incyte capacitance probes; CHO N-1 perfusion; 5 L bench, 200 L pilot, 500 L GMP; six mAb cell lines Capacitance linear with offline viable cell density at all densities tested, up to 130 million cells/mL Used as a real-time control input; no drift event reported across the platform development runs Capacitance-driven cell-specific perfusion control cut media use by about 25% with no harm to growth; small-scale data scaled up cleanly to GMP
Moore 2019 [2] In situ biocapacitance probes; commercial GMP CHO process; small and large scale bioreactors Characterised lower limit of quantitation and probe-to-probe consistency; scalability demonstrated small to large scale Consistent results across six consecutive GMP seed trains; signal also flagged a culture salt-balance shift Biocapacitance is fit for GMP process control: automated seed-train inoculation and predictive glucose-demand feeding
Metze 2019 [3] In-line capacitance probe; CHO culture in 250 mL small-scale bioreactors; single frequency vs frequency scanning Single frequency 16 to 23% relative error; multivariate frequency scanning 5.5 to 11% relative error Dilution and feed deviations detected immediately (6.7 to 13.2% error under challenge) Frequency scanning with multivariate analysis brings capacitance accuracy inside the offline reference's own acceptance band
Schini 2023 [4] Dielectric spectroscopy conversion model; CHO culture; Cole-Cole and Maxwell-Wagner equations In-process adjustment of cell-specific parameters improved viable cell concentration estimate by 69% vs a purely mechanistic model Sensitivity traced to membrane capacitance and internal conductivity, which shift with clone and process A capacitance probe is only as accurate as its conversion model; periodic offline adjustment is needed for best accuracy
Downey 2014 [5] Dielectric-spectroscopy frequency scanning; CHO fed-batch; novel "area ratio" beta-dispersion shape metric Area ratio metric predicted viable cell volume accurately through a full fed-batch run regardless of cell state Beta-dispersion shape changes used as an indicator of cell health, not just biomass Quantifying the shape of the frequency scan, not just amplitude, enables accurate VCV measurement late in culture
Sun 2025 [7] In-line dielectric spectroscopy; CHO perfusion; segmented adaptive PLS (SA-PLS) model; multiple clones SA-PLS model held viable cell density near target with notable precision through stationary and decline phases First-order derivative pre-processing reduced variability across training datasets Adaptive modelling extends capacitance accuracy into the late-culture regime and enables closed-loop perfusion control
Lomont 2024 [8] In situ dielectric spectroscopy across 25 frequencies; live-virus vaccine production; univariate vs PLS multivariate PLS models predicted both viable cell density and viability; markedly better than single-frequency models during cell death Continuous real-time signal throughout the process; sparse offline sampling no longer the constraint Dielectric spectroscopy is a viable PAT tool beyond mAbs, including for live-virus vaccine processes

Every row is a separate peer-reviewed publication; see References section for full citations. Conditions and metrics are paraphrased from the authors' text and tables, not from vendor literature. Rittershaus 2022 used Hamilton Incyte probes specifically; the remaining rows characterise the radio-frequency dielectric-spectroscopy measurement class the Incyte belongs to.

Limitations and failure modes reported

Across the reviewed studies, the following limitations and failure modes recurred. Each bullet is tagged with the specific citation that describes it. None of these are Incyte-specific defects; they are properties of the dielectric-spectroscopy measurement that any capacitance probe shares.

When the literature recommends the Hamilton Incyte Arc

Recommended for

  • Real-time viable cell density for perfusion and N-1 intensification, including automated cell-specific perfusion-rate control [1]
  • Scale-up programmes where the same capacitance signal is carried from bench through pilot to GMP scale [1]
  • cGMP manufacturing that needs a documented lower limit of quantitation and probe-to-probe consistency for process control [2]
  • Robust biomass accuracy through cell-diameter changes, using frequency scanning with multivariate modelling [3]

Caveats / not recommended for

  • Do not treat the single-frequency reading as a viable cell count late in culture; pair it with offline counts or use frequency scanning [3]
  • It is not a substitute for an apoptosis assay; capacitance lags early-apoptotic detection because intact membranes still polarise [9]
  • The conversion model needs recalibration per clone and process; cell-specific parameters are not transferable as-is [4]
  • Decisions that require a published independent head-to-head against the Aber FUTURA; that benchmark is not in the literature reviewed here [6]

Use cases documented in the literature

Specific deployments reported in the cited studies. Each card corresponds to a real published bioprocess use case.

Perfusion intensification
N-1 perfusion seed control

BMS used Hamilton Incyte probes to control the N-1 perfusion rate from real-time viable cell density, holding a constant cell-specific perfusion rate and cutting media use by about 25%.

[1]
GMP process control
Automated seed-train inoculation

Biogen used biocapacitance to automate seed-train dilution across six consecutive GMP CHO seed trains and to predict future glucose demand.

[2]
Closed-loop control
Perfusion VCD auto-control

WuXi Biologics built a real-time viable cell density auto-control loop for perfusion using a segmented adaptive PLS model on the dielectric signal.

[7]
Beyond antibodies
Live-virus vaccine monitoring

Merck used in situ dielectric spectroscopy across 25 frequencies to predict viable cell density and viability in real time during live-virus vaccine production.

[8]

Comparing the Hamilton Incyte Arc against alternatives?

The Sensor Selection Tool takes 6 questions about your scale, modality, vessel, and budget and returns ranked sensor recommendations, including alternatives to the Hamilton Incyte Arc.

Open the Sensor Selection Tool

User reviews from bioprocess engineers

Real-world experience from engineers who deployed the Hamilton Incyte Arc. All reviews are moderated before publishing. Share your own below: 2 minutes, anonymous option available.

Frequently asked questions

What is the Hamilton Incyte Arc?
The Incyte Arc is Hamilton's in-line viable cell density sensor. It is a radio-frequency dielectric spectroscopy (capacitance) probe: an electric field in the 300 kHz to 10 MHz range polarises intact cell membranes, and the measured permittivity is proportional to viable cell volume. Dead cells, debris, microcarriers, and gas bubbles do not hold the charge and are largely ignored. The Arc version integrates the microtransmitter directly into the probe head, so no separate transmitter cabinet is needed. It is one of the two capacitance platforms that dominate cGMP mammalian biomass monitoring, alongside the Aber FUTURA.
Does the Incyte measure viable cell number or viable cell volume?
Capacitance probes such as the Incyte measure viable cell volume, the polarisable membrane-bound volume, not viable cell number directly [6]. Permittivity is converted to a viable cell density using a calibration or conversion model. This distinction matters late in culture: when mean cell diameter changes, a single-frequency reading can diverge from an offline viable cell count even though the probe itself is working correctly [3]. For background on what the underlying growth curve looks like, see the CHO growth curve guide.
How accurate is the Hamilton Incyte capacitance probe?
In a published BMS deployment, capacitance correlated linearly with offline viable cell density up to 130 million cells/mL across bench, pilot, and GMP scales [1]. The reported accuracy depends heavily on the modelling approach: a Sartorius study found single-frequency permittivity carried 16 to 23% relative error, while multivariate analysis of frequency-scanning data cut this to 5.5 to 11% [3]. A Merck KGaA study reported that adjusting cell-specific parameters in the conversion model with periodic offline samples improved viable cell concentration estimates by 69% over a purely mechanistic model [4].
Why does the capacitance signal diverge from trypan blue counts late in a culture?
Two effects combine. First, the signal tracks viable cell volume, so a change in mean cell diameter shifts permittivity without any change in cell number [3]. Second, during early apoptosis the cell membrane remains intact and still polarises, so capacitance can read higher than a trypan blue count that has already started detecting dye-permeable cells. A University of Manitoba study showed bulk capacitance tracked intermediate-stage apoptotic counts, which is why the divergence is best understood as a population shift between dielectric sub-populations rather than probe error [9].
Is the Incyte Arc available for single-use bioreactors?
Yes. Alongside the reusable Incyte Arc probe (PG13.5 connection, autoclave and SIP compatible), Hamilton offers Incyte SU sensor elements that are pre-installed as an integral wall-mounted patch in rigid single-use vessels of roughly 3.2 litres and larger. The single-use elements ship pre-calibrated and gamma-irradiated and connect to an Arc Module for read-out. The published literature reviewed here used the reusable probe format. For the wider single-use trade-off, see the single-use vs stainless steel comparison.
Can the Incyte control perfusion and feed rates automatically?
Yes, and this is the most documented use case. A BMS study used an in-line capacitance probe to automatically adjust the N-1 perfusion rate from real-time viable cell density, holding a constant cell-specific perfusion rate and cutting media use by about 25% versus a volume-specific approach [1]. A separate WuXi Biologics study built a real-time viable cell density auto-control loop for perfusion using a segmented adaptive PLS model on the dielectric signal, maintaining the target density with good precision through stationary and decline phases [7]. You can model the underlying media throughput with the perfusion calculator.
Single-frequency or frequency scanning - which should I use?
Single-frequency permittivity is simple and works well during exponential growth. For robust accuracy through cell-diameter changes and into stationary and decline phases, the literature favours frequency scanning combined with multivariate modelling. A Sartorius study reduced relative error from 16 to 23% (single frequency) down to 5.5 to 11% using multivariate analysis of a frequency scan, and detected dilution and feed deviations immediately [3]. A 2014 study showed that quantifying the shape of the beta dispersion from a frequency scan predicts viable cell volume accurately through a whole fed-batch run [5]. The Incyte supports both a dual-frequency mode and full frequency scanning.
How does the Incyte compare with the Aber FUTURA?
Both are radio-frequency dielectric capacitance probes measuring viable cell volume, and both are widely deployed in cGMP mammalian manufacturing [6]. The published deployment literature for the Incyte centres on the Arc integrated-transmitter format and single-use compatibility, while the Aber literature is broader and includes large-scale CHO scale-up and conductivity-channel diagnostics. No peer-reviewed independent head-to-head benchmark of the two platforms exists in the literature reviewed here. See the capacitance vs optical biomass comparison and the Aber FUTURA review for the wider trade-off matrix.

References

  1. Rittershaus ESC, Rehmann MS, Xu J, He Q, Hill C, Swanberg J, Borys MC, Li ZJ, Khetan A (2022). N-1 Perfusion Platform Development Using a Capacitance Probe for Biomanufacturing. Bioengineering (Basel) 9(4):128. DOI: 10.3390/bioengineering9040128.
  2. Moore B, Sanford R, Zhang A (2019). Case study: The characterization and implementation of dielectric spectroscopy (biocapacitance) for process control in a commercial GMP CHO manufacturing process. Biotechnology Progress 35(3):e2782. DOI: 10.1002/btpr.2782.
  3. Metze S, Blioch S, Matuszczyk J, Greller G, Grimm C, Scholz J, Hoehse M (2019). Multivariate data analysis of capacitance frequency scanning for online monitoring of viable cell concentrations in small-scale bioreactors. Analytical and Bioanalytical Chemistry 412(9):2089-2102. DOI: 10.1007/s00216-019-02096-3.
  4. Schini A, De Canditiis B, Sanchez C, Pierrelee M, Voltz KE, Jourdainne L (2023). Influence of cell specific parameters in a dielectric spectroscopy conversion model used to monitor viable cell density in bioreactors. Biotechnology Journal 18(11):e2300028. DOI: 10.1002/biot.202300028.
  5. Downey BJ, Graham LJ, Breit JF, Glutting NK (2014). A novel approach for using dielectric spectroscopy to predict viable cell volume (VCV) in early process development. Biotechnology Progress 30(2):479-487. DOI: 10.1002/btpr.1845.
  6. Bergin A, Carvell J, Butler M (2022). Applications of bio-capacitance to cell culture manufacturing. Biotechnology Advances 61:108048. DOI: 10.1016/j.biotechadv.2022.108048.
  7. Sun Y, Zhang Q, He Y, Chen D, Wang Z, Zheng X, Fang M, Zhou H (2025). Real-Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In-Line Dielectric Spectroscopy With Segmented Adaptive PLS Model. Biotechnology and Bioengineering 122(4):858-869. DOI: 10.1002/bit.28930.
  8. Lomont JP, Smith JP (2024). In situ process analytical technology for real time viable cell density and cell viability during live-virus vaccine production. International Journal of Pharmaceutics 649:123630. DOI: 10.1016/j.ijpharm.2023.123630.
  9. Braasch K, Nikolic-Jaric M, Cabel T, Salimi E, Bridges GE, Thomson DJ, Butler M (2013). The changing dielectric properties of CHO cells can be used to determine early apoptotic events in a bioprocess. Biotechnology and Bioengineering 110(11):2902-2914. DOI: 10.1002/bit.24976.

Vendor product pages referenced for spec values: Hamilton Incyte Arc product page, Hamilton Incyte SU sensor elements, Hamilton viable cell density sensors overview. Spec values are vendor claims; all field-performance figures in this review are drawn exclusively from the peer-reviewed publications cited above.